探索阿尔茨海默病和质母细胞瘤的共同治疗目标,使用网络药理学和蛋白质-蛋白质相互作用方法
Sushma Pradeep1,2, M R Sai Chakith3, S R Sindhushree1
1Department of Biotechnology and Bioinformatics, School of Life Sciences, JSS Academy of Higher Education and Research, Mysuru, Karnataka, India.
这项研究探讨了Eclipta alba化合物用于阿尔茨海默病 (AD) 和质母细胞瘤 (GBM). 丁作为一种双重向治疗剂,通过有效地结合参与这两种神经疾病的关键基因,显示出了前途.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 和质母细胞瘤 (GBM) 分享了神经炎症和氧化应激等分子机制.
- 目前对AD和GBM的治疗方法有限,需要新的治疗策略.
- 识别共享的分子点对于开发有效的双作用疗法至关重要.
研究的目的:
- 为了研究生物活性化合物从*Eclipta alba*对AD和GBM的治疗潜力.
- 通过网络药理学识别共同的分子标和潜在的候选药物.
- 通过计算方法评估有前途的化合物的疗效和安全性.
主要方法:
- 网络药理学分析确定了AD和GBM之间的617个共同基因.
- 使用Cytoscape优先考虑关键枢纽基因 (TP53,STAT3,AKT1,IL6).
- 进行了分子对接,动力学模拟和药理动力学/毒性评估.
主要成果:
- 来自*Eclipta alba*的素显示出与IL6标具有很高的结合亲和力.
- 分子动力学和结合能量的计算证实了醇-IL6复合物的稳定性.
- 氨酸表现出有利的药理动力学特性和低毒性,表明其具有治疗潜力.
结论:
- 丁醇是一种有前途的多目标治疗药物,用于AD和GBM.
- 计算结果为未来的"体外"和"体内"验证提供了基础.
- 这项研究为开发神经和瘤疾病的双重向治疗开辟了新的途径.
更多相关视频
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
11:49Quantitative Proteomics Workflow using Multiple Reaction Monitoring Based Detection of Proteins from Human Brain Tissue
Published on: August 28, 2021
相关概念视频
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Protein-protein Interfaces
Alzheimer's Disease: Treatment
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Targeted Cancer Therapies
There are several types of targeted therapies against...
